Hyperopic laser in situ keratomileusis in eyes with previous radial keratotomy

Deniz Oral, Shady T. Awwad, Michael S. Seward, Robert W Bowman, James P McCulley, Harrison D Cavanagh

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

PURPOSE: To assess the safety and efficacy of hyperopic laser in situ keratomileusis (LASIK) in eyes with previous radial keratotomy (RK). SETTING: Zale Lipshy University Hospital Laser Center for Vision, University of Texas Southwestern Medical Center, Dallas, Texas, USA. METHODS: Thirty-eight eyes of 25 patients were treated with LASIK for secondary hyperopia after RK using a Visx Star S2, S3, S4, or LADARVision excimer laser. Retreatment was done in 7 eyes. The main outcome measures were manifest refraction spherical equivalent (MRSE), uncorrected visual acuity (UCVA), best spectacle corrected visual acuity (BSCVA), predictability of treatment, and complications. RESULTS: Preoperative mean MRSE was +2.39 diopters (D) ± 1.28 (SD) (range +0.87 to +6.00 D). At the last visit (25 eyes with minimum follow-up of 12 months, including retreatments), the mean follow-up was 23.3 ± 7.3 months (range 12 to 34 months), the mean MRSE was +0.11 ± 0.71 D, and the UCVA was 20/40 or better in 24 eyes (96%). Although no significant change in the mean MRSE was observed, the postoperative mean refractive cylinder showed a gradual increase over the follow-up period. No eye lost more than 2 lines of BSCVA. CONCLUSIONS: Laser in situ keratomileusis was a safe and effective treatment with good predictability for the correction of consecutive hyperopia after RK. Cylindrical errors were difficult to correct, and astigmatic correction tended to regress over time. Retreatments are safe when old flaps were relifted.

Original languageEnglish (US)
Pages (from-to)1561-1568
Number of pages8
JournalJournal of Cataract and Refractive Surgery
Volume31
Issue number8
DOIs
StatePublished - Aug 2005

Fingerprint

Radial Keratotomy
Laser In Situ Keratomileusis
Visual Acuity
Retreatment
Hyperopia
Excimer Lasers
Lasers
Outcome Assessment (Health Care)
Safety
Therapeutics

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Hyperopic laser in situ keratomileusis in eyes with previous radial keratotomy. / Oral, Deniz; Awwad, Shady T.; Seward, Michael S.; Bowman, Robert W; McCulley, James P; Cavanagh, Harrison D.

In: Journal of Cataract and Refractive Surgery, Vol. 31, No. 8, 08.2005, p. 1561-1568.

Research output: Contribution to journalArticle

@article{6d9038d5d03f4acf92db71e6c21a6ca4,
title = "Hyperopic laser in situ keratomileusis in eyes with previous radial keratotomy",
abstract = "PURPOSE: To assess the safety and efficacy of hyperopic laser in situ keratomileusis (LASIK) in eyes with previous radial keratotomy (RK). SETTING: Zale Lipshy University Hospital Laser Center for Vision, University of Texas Southwestern Medical Center, Dallas, Texas, USA. METHODS: Thirty-eight eyes of 25 patients were treated with LASIK for secondary hyperopia after RK using a Visx Star S2, S3, S4, or LADARVision excimer laser. Retreatment was done in 7 eyes. The main outcome measures were manifest refraction spherical equivalent (MRSE), uncorrected visual acuity (UCVA), best spectacle corrected visual acuity (BSCVA), predictability of treatment, and complications. RESULTS: Preoperative mean MRSE was +2.39 diopters (D) ± 1.28 (SD) (range +0.87 to +6.00 D). At the last visit (25 eyes with minimum follow-up of 12 months, including retreatments), the mean follow-up was 23.3 ± 7.3 months (range 12 to 34 months), the mean MRSE was +0.11 ± 0.71 D, and the UCVA was 20/40 or better in 24 eyes (96{\%}). Although no significant change in the mean MRSE was observed, the postoperative mean refractive cylinder showed a gradual increase over the follow-up period. No eye lost more than 2 lines of BSCVA. CONCLUSIONS: Laser in situ keratomileusis was a safe and effective treatment with good predictability for the correction of consecutive hyperopia after RK. Cylindrical errors were difficult to correct, and astigmatic correction tended to regress over time. Retreatments are safe when old flaps were relifted.",
author = "Deniz Oral and Awwad, {Shady T.} and Seward, {Michael S.} and Bowman, {Robert W} and McCulley, {James P} and Cavanagh, {Harrison D}",
year = "2005",
month = "8",
doi = "10.1016/j.jcrs.2005.01.021",
language = "English (US)",
volume = "31",
pages = "1561--1568",
journal = "Journal of Cataract and Refractive Surgery",
issn = "0886-3350",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Hyperopic laser in situ keratomileusis in eyes with previous radial keratotomy

AU - Oral, Deniz

AU - Awwad, Shady T.

AU - Seward, Michael S.

AU - Bowman, Robert W

AU - McCulley, James P

AU - Cavanagh, Harrison D

PY - 2005/8

Y1 - 2005/8

N2 - PURPOSE: To assess the safety and efficacy of hyperopic laser in situ keratomileusis (LASIK) in eyes with previous radial keratotomy (RK). SETTING: Zale Lipshy University Hospital Laser Center for Vision, University of Texas Southwestern Medical Center, Dallas, Texas, USA. METHODS: Thirty-eight eyes of 25 patients were treated with LASIK for secondary hyperopia after RK using a Visx Star S2, S3, S4, or LADARVision excimer laser. Retreatment was done in 7 eyes. The main outcome measures were manifest refraction spherical equivalent (MRSE), uncorrected visual acuity (UCVA), best spectacle corrected visual acuity (BSCVA), predictability of treatment, and complications. RESULTS: Preoperative mean MRSE was +2.39 diopters (D) ± 1.28 (SD) (range +0.87 to +6.00 D). At the last visit (25 eyes with minimum follow-up of 12 months, including retreatments), the mean follow-up was 23.3 ± 7.3 months (range 12 to 34 months), the mean MRSE was +0.11 ± 0.71 D, and the UCVA was 20/40 or better in 24 eyes (96%). Although no significant change in the mean MRSE was observed, the postoperative mean refractive cylinder showed a gradual increase over the follow-up period. No eye lost more than 2 lines of BSCVA. CONCLUSIONS: Laser in situ keratomileusis was a safe and effective treatment with good predictability for the correction of consecutive hyperopia after RK. Cylindrical errors were difficult to correct, and astigmatic correction tended to regress over time. Retreatments are safe when old flaps were relifted.

AB - PURPOSE: To assess the safety and efficacy of hyperopic laser in situ keratomileusis (LASIK) in eyes with previous radial keratotomy (RK). SETTING: Zale Lipshy University Hospital Laser Center for Vision, University of Texas Southwestern Medical Center, Dallas, Texas, USA. METHODS: Thirty-eight eyes of 25 patients were treated with LASIK for secondary hyperopia after RK using a Visx Star S2, S3, S4, or LADARVision excimer laser. Retreatment was done in 7 eyes. The main outcome measures were manifest refraction spherical equivalent (MRSE), uncorrected visual acuity (UCVA), best spectacle corrected visual acuity (BSCVA), predictability of treatment, and complications. RESULTS: Preoperative mean MRSE was +2.39 diopters (D) ± 1.28 (SD) (range +0.87 to +6.00 D). At the last visit (25 eyes with minimum follow-up of 12 months, including retreatments), the mean follow-up was 23.3 ± 7.3 months (range 12 to 34 months), the mean MRSE was +0.11 ± 0.71 D, and the UCVA was 20/40 or better in 24 eyes (96%). Although no significant change in the mean MRSE was observed, the postoperative mean refractive cylinder showed a gradual increase over the follow-up period. No eye lost more than 2 lines of BSCVA. CONCLUSIONS: Laser in situ keratomileusis was a safe and effective treatment with good predictability for the correction of consecutive hyperopia after RK. Cylindrical errors were difficult to correct, and astigmatic correction tended to regress over time. Retreatments are safe when old flaps were relifted.

UR - http://www.scopus.com/inward/record.url?scp=23944523104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944523104&partnerID=8YFLogxK

U2 - 10.1016/j.jcrs.2005.01.021

DO - 10.1016/j.jcrs.2005.01.021

M3 - Article

C2 - 16129292

AN - SCOPUS:23944523104

VL - 31

SP - 1561

EP - 1568

JO - Journal of Cataract and Refractive Surgery

JF - Journal of Cataract and Refractive Surgery

SN - 0886-3350

IS - 8

ER -